Use of Binding Energy by an RNA Enzyme for Catalysis by Positioning and Substrate Destabilization
Overview
Affiliations
A fundamental catalytic principle for protein enzymes in the use of binding interactions away from the site of chemical transformation for catalysis. We have compared the binding and reactivity of a series of oligonucleotide substrates and products of the Tetrahymena ribozyme, which catalyzes a site-specific phosphodiester cleavage reaction: CCCUCUpA+G<-->CCCUCU-OH+GpA. The results suggest that this RNA enzyme, like protein enzymes, can utilize binding interactions to achieve substantial catalysis via entropic fixation and substrate destabilization. The stronger binding of the all-ribose oligonucleotide product compared to an analog with a terminal 3' deoxyribose residue gives an effective concentration of 2200 M for the 3' hydroxyl group, a value approaching those obtained with protein enzymes and suggesting the presence of a structurally well defined active site capable of precise positioning. The stabilization from tertiary binding interactions is 40-fold less for the oligonucleotide substrate than the oligonucleotide product, despite the presence of the reactive phosphoryl group in the substrate. This destabilization is accounted for by a model in which tertiary interactions away from the site of bond cleavage position the electron-deficient 3' bridging phosphoryl oxygen of the oligonucleotide substrate next to an electropositive Mg ion. As the phosphodiester bond breaks and this 3' oxygen atom develops a negative charge in the transition state, the weak interaction of the substrate with Mg2+ becomes strong. These strategies of "substrate destabilization" and "transition state stabilization" provide estimated rate enhancements of approximately 280- and approximately 60-fold, respectively. Analogous substrate destabilization by a metal ion or hydrogen bond donor may be used more generally by RNA and protein enzymes catalyzing reactions of phosphate esters.
Snapshots of the second-step self-splicing of Tetrahymena ribozyme revealed by cryo-EM.
Li S, Palo M, Zhang X, Pintilie G, Zhang K Nat Commun. 2023; 14(1):1294.
PMID: 36928031 PMC: 10020454. DOI: 10.1038/s41467-023-36724-5.
Small Molecule Catalysts with Therapeutic Potential.
Ney Y, Nasim M, Kharma A, Youssef L, Jacob C Molecules. 2018; 23(4).
PMID: 29584669 PMC: 6017662. DOI: 10.3390/molecules23040765.
Sengupta R, van Schie S, Giambasu G, Dai Q, Yesselman J, York D RNA. 2015; 22(1):32-48.
PMID: 26567314 PMC: 4691833. DOI: 10.1261/rna.053710.115.
A kinetic and thermodynamic framework for the Azoarcus group I ribozyme reaction.
Gleitsman K, Herschlag D RNA. 2014; 20(11):1732-46.
PMID: 25246656 PMC: 4201826. DOI: 10.1261/rna.044362.114.
Bonneau E, Legault P Biochemistry. 2013; 53(3):579-90.
PMID: 24364590 PMC: 3906864. DOI: 10.1021/bi401484a.